Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC

Abroad (travel likely)Recruiting

Conditions

Oropharyngeal Squamous Cell Carcinoma · Carcinoma, Squamous Cell · Head and Neck Squamous Cell Carcinoma · Oropharynx Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Mayo Clinic, Rochester, Minnesota, United States

  • University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Tuvara King) · tjking@med.unc.edu · 919-966-4432
    Contact: Principal Investigator (Wendell Yarbrough, MD)
  • Trident Medical Center (HCA Healthcare ), North Charleston, South Carolina, United States

    Contact: Study coordinator (Vera Markovic) · Vera.Markovic@hcahealthcare.com · 843-998-2819
    Contact: Study coordinator (David Neskey, MD) · david.neskey@sarahcannon.com · 843-998-2819
    Contact: Principal Investigator (David Neskey, MD)
Study leads
  • Wendell Yarbrough, MD

    Principal Investigator

    UNC Chapel Hill